Nano-X Imaging Ltd. Stock Price, News & Analysis

Nano-X Imaging Ltd (NNOX) reported Q3 2020 results, indicating a net loss of $11.1 million, an increase from $1.9 million in Q3 2019. The company ended the quarter with $240 million in cash and no debt. Notably, Nano-X signed an agreement with SPI Medical to deploy 630 Nanox.ARC units across Mexico and Guatemala, increasing total contracts to 5,150 units in 13 countries. The company aims to achieve 15,000 system deployments by 2024. An IPO in August raised around $190 million to support these initiatives.

NANO-X IMAGING LTD (NASDAQ: NNOX) announced participation in three upcoming investor conferences. Key events include the Berenberg US CEO Conference on November 12, 2020, at 9:00 AM ET, the Jefferies Virtual London Healthcare Conference on November 17, 2020, at 5:35 AM ET, and the Canaccord Genuity Virtual MedTech & Diagnostics Forum on November 19, 2020, at 9:00 AM ET. Each event will have a live webcast available for registration. The company aims to leverage its innovative medical imaging technology for affordable healthcare solutions.

NANO-X IMAGING LTD has partnered with Ambra Health to enhance the exchange of medical imaging data across U.S. hospitals. This collaboration integrates Ambra’s cloud-based image management solution with the upcoming Nanox.ARC system, pending FDA approval. Ambra's platform, used in over 50 countries, manages over eight billion images, aiming to streamline workflows and improve patient communication. The partnership signifies a step towards more efficient medical data management, with intentions to provide seamless image transfer and enhance data privacy once authorized.

NANO-X IMAGING LTD (NASDAQ: NNOX) will release its third quarter 2020 financial results on November 9, 2020, prior to market opening. A conference call and webcast is scheduled for 8:30 AM ET on the same day, where management will discuss the results. Nanox is focused on innovative medical imaging technology, developing a digital X-ray source aimed at reducing imaging costs. The company seeks collaboration with leading healthcare entities to enhance accessibility to early detection imaging services. For more details, visit www.nanox.vision.

Nanox Imaging Ltd (NASDAQ: NNOX) is set to showcase its advanced medical imaging technology, including the Nanox.SOURCE and Nanox.ARC systems, at the RSNA 2020 event from November 29 to December 5 in Chicago. The demonstration, led by CEO Ran Poliakine, will feature live imaging sessions and discussions about clinical applications, aiming to enhance global access to preventive healthcare through affordable imaging solutions. With two-thirds of the world lacking medical imaging access, Nanox's initiative aims to address this gap and promote early detection.

NANO-X IMAGING LTD (NASDAQ: NNOX) appointed Gilad Yron as Chief Business Officer to enhance its MSaaS agreements and refine commercial strategy. His role aims to oversee customer-facing activities and lead the deployment of over 5,100 Nanox.ARC systems, pending regulatory approvals. Ran Poliakine, Chairman and CEO, emphasized the importance of a world-class team to drive success and democratize medical imaging. Yron's prior experience includes leadership roles at Kornit Digital and Stratasys Ltd, indicating a strong focus on innovation in technology.

NANO-X IMAGING LTD (NASDAQ: NNOX) announced that its CEO, Ran Poliakine, will participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit from September 21-23, 2020. The presentation is scheduled for September 22, 2020, at 9:10 am ET. The event will be webcast live, with access available through both a dedicated link and the company's website. Nanox focuses on developing a cost-effective digital X-ray source for real-world medical applications aimed at improving early detection services.

NANO-X IMAGING LTD (NASDAQ: NNOX) responded to unusual trading activities attributed to a Citron Research report dated September 15, 2020. The Company refutes the report's allegations, labeling them as baseless and misleading. Nanox is investigating the claims and promises to provide further clarity as necessary. Founded by Ran Poliakine, Nanox is focused on developing a cost-effective digital X-ray source aimed at improving medical imaging accessibility.

NANO-X IMAGING LTD (NASDAQ: NNOX) announced participation in two investor conferences. The first event is the Jefferies Asia Forum on September 16, 2020, at 4:00 PM HK time, followed by the Cantor Virtual Global Healthcare Conference on September 15, 2020, at 9:20 AM EDT. Audio for both events will be available via webcast on the company's website, with archives accessible for 90 days. Founded by Ran Poliakine, Nanox develops innovative digital X-ray technology aimed at reducing medical imaging costs and improving accessible healthcare.